Table III.
Subject satisfaction at end of study
| Variable | Verum (n = 19) n (%) | Placebo (n = 9) n (%) | p-value |
|---|---|---|---|
| Pain | |||
| Severe | 0 (0) | 1 (11.1) | 0.482 |
| Moderate | 10 (52.6) | 4 (44.4) | |
| Mild | 9 (47.4) | 4 (44.4) | |
| Clinical outcome | |||
| Much better | 3 (15.8) | 0 (0) | 0.272 |
| Somewhat better | 10 (52.6) | 4 (44.4) | |
| No change | 6 (31.6) | 4 (44.4) | |
| Somewhat worse | 0 (0) | 1 (11.1) | |
| Willing to pay, € | |||
| 100-200 | 1 (5.3) | 2 (22.2) | 0.135 |
| Up to 100 | 13 (68.4) | 3 (33.3) | |
| Nothing | 5 (26.3) | 4 (44.4) | |
| Recommendation | |||
| Yes | 16 (84.2) | 5 (55.6) | 0.165 |
| No | 3 (15.8) | 4 (44.4) |
Group differences were assessed using Fisher’s exact test.